JFS Wealth Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-190
| Closed | -$28.6K | – | 1893 |
|
|
2025
Q1 | $28.6K | Sell |
190
-15
| -7% | -$2.26K | ﹤0.01% | 586 |
|
|
2024
Q4 | $37.8K | Sell |
205
-3
| -1% | -$554 | ﹤0.01% | 512 |
|
|
2024
Q3 | $41K | Sell |
208
-2
| -1% | -$394 | ﹤0.01% | 505 |
|
|
2024
Q2 | $43.4K | Buy |
210
+4
| +2% | +$826 | ﹤0.01% | 445 |
|
|
2024
Q1 | $55.8K | Buy |
206
+8
| +4% | +$2.17K | ﹤0.01% | 410 |
|
|
2023
Q4 | $46.8K | Sell |
198
-15
| -7% | -$3.55K | ﹤0.01% | 414 |
|
|
2023
Q3 | $41.7K | Buy |
213
+7
| +3% | +$1.37K | ﹤0.01% | 401 |
|
|
2023
Q2 | $43.3K | Buy |
206
+4
| +2% | +$841 | ﹤0.01% | 388 |
|
|
2023
Q1 | $40.8K | Sell |
202
-3
| -1% | -$605 | ﹤0.01% | 398 |
|
|
2022
Q4 | $44.7K | Buy |
205
+7
| +4% | +$1.53K | ﹤0.01% | 381 |
|
|
2022
Q3 | $39K | Sell |
198
-7
| -3% | -$1.38K | ﹤0.01% | 433 |
|
|
2022
Q2 | $44K | Buy |
205
+10
| +5% | +$2.15K | ﹤0.01% | 418 |
|
|
2022
Q1 | $55K | Sell |
195
-1
| -0.5% | -$282 | 0.01% | 405 |
|
|
2021
Q4 | $74K | Buy |
+196
| New | +$74K | 0.01% | 357 |
|